Abel Hall LLC’s GSK GSK Stock Holding History

Abel Hall LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$736K	Sell	14,039 -777	-5%	-$41.1K	0.13%	135
2026 Q1	$818K	Sell	14,816 -8,876	-37%	-$481K	0.17%	95
2025 Q4	$1.16M	Buy	23,692 +9,359	+65%	+$437K	0.27%	50
2025 Q3	$619K	Sell	14,333 -497	-3%	-$19.4K	0.25%	63
2025 Q2	$569K	Buy	14,830 +294	+2%	+$11.2K	0.26%	64
2025 Q1	$563K	Buy	14,536 +1,763	+14%	+$64.5K	0.34%	46
2024 Q4	$432K	Sell	12,773 -672	-5%	-$24.2K	0.28%	59
2024 Q3	$550K	Buy	13,445 +126	+0.9%	+$5.16K	0.36%	41
2024 Q2	$513K	Buy	13,319 +163	+1%	+$6.86K	0.36%	41
2024 Q1	$564K	Buy	13,156 +107	+0.8%	+$4.41K	0.42%	36
2023 Q4	$484K	Buy	+13,049	New	+$468K	0.41%	41

Other funds holding GSK

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

FVWA

Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

KFP

Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Transmarket Holdings Chicago, Illinois $136M AUM

Abel Hall LLC's GSK Position: Q2 2026 in Review

Abel Hall LLC reduced its GSK (GSK) stake by 5.2% in Q2 2026, selling an estimated $41.1K and leaving 14,039 shares worth $736K. The position accounts for 0.13% of the portfolio, ranked #135.

Abel Hall LLC first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.16M in Q4 2025. 364 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Abel Hall LLC held 14,039 shares of GSK worth $736K as of Q2 2026.
Abel Hall LLC sold 777 GSK shares in Q2 2026, an estimated $41.1K.
GSK made up 0.13% of Abel Hall LLC's portfolio in Q2 2026, its #135 holding.
Abel Hall LLC first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
Abel Hall LLC's GSK position peaked at $1.16M in Q4 2025.
364 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.